Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain

Primary immunodeficiency diseases (PID), which are comprised of over 400 genetic disorders, occur when a component of the immune system is diminished or dysfunctional. Patients with PID who require immunoglobulin (IG) replacement therapy receive intravenous IG (IVIG) or subcutaneous IG (SCIG), each...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsina, Laia, Montoro, J. Bruno, Moral, Pedro Moral, Neth, Olaf, Pica, Marta Ortiz, Sánchez-Ramón, Silvia, Presa, María, Oyagüez, Itziar, Casado, Miguel Ángel, González-Granado, Luis Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964571/
https://www.ncbi.nlm.nih.gov/pubmed/34546485
http://dx.doi.org/10.1007/s10198-021-01378-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964571/
https://www.ncbi.nlm.nih.gov/pubmed/34546485
http://dx.doi.org/10.1007/s10198-021-01378-x

Ejemplares similares